Abeona Therapeutics Files 8-K Report
Ticker: ABEO · Form: 8-K · Filed: Apr 29, 2025 · CIK: 318306
| Field | Detail |
|---|---|
| Company | Abeona Therapeutics Inc. (ABEO) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
ABEONA THERAPEUTICS FILED AN 8-K. CHECK FOR UPDATES.
AI Summary
On April 29, 2025, Abeona Therapeutics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Abeona Therapeutics is providing updated information to the SEC, which could include material events or financial updates relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K, and the provided excerpt does not contain information about significant negative events, financial distress, or major strategic shifts.
Key Players & Entities
- ABEONA THERAPEUTICS INC. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 001-15771 (identifier) — Commission File Number
- 83-0221517 (identifier) — I.R.S. Employer Identification No.
- 6555 Carnegie Ave , 4th Floor Cleveland , OH 44103 (address) — Principal executive offices
- April 29, 2025 (date) — Date of report
FAQ
What specific "Other Events" are being reported by Abeona Therapeutics Inc. in this 8-K filing?
The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported, only that this item is included.
What is the significance of the "Financial Statements and Exhibits" section in this filing?
This section indicates that Abeona Therapeutics Inc. is providing updated financial information or exhibits as part of the 8-K filing, which could include financial statements or related documents.
When was this 8-K report filed with the SEC?
The report was filed on April 29, 2025.
What is Abeona Therapeutics Inc.'s principal executive office address?
The principal executive offices are located at 6555 Carnegie Ave, 4th Floor, Cleveland, OH 44103.
What is Abeona Therapeutics Inc.'s Commission File Number?
Abeona Therapeutics Inc.'s Commission File Number is 001-15771.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2025 regarding ABEONA THERAPEUTICS INC. (ABEO).